CVKD – cadrenal therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion [Yahoo! Finance]
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion
CVKD: Phase 2 HIT Results Show Encouraging Reduction in Thrombotic Events [Yahoo! Finance]
Cadrenal Therapeutics Announces Phase 2 Results with Encouraging Reductions in Thrombotic Events for CAD-1005 in HIT, Supporting Clinical Advancement
Cadrenal Therapeutics Highlights High Incidence of Thrombotic Complications in Heparin-Induced Thrombocytopenia (HIT) at the J.P. Morgan Healthcare Conference and VLX-1005 as a Potential Therapeutic Solution as the First and Only Selective 12-LOX Inhibito
Form 8-K Cadrenal Therapeutics, For: Feb 24
Form 424B3 Cadrenal Therapeutics,
Form EFFECT Cadrenal Therapeutics,
Form D Cadrenal Therapeutics,
Form 4 Cadrenal Therapeutics, For: Dec 29 Filed by: Szot Matthew K
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.